Morphologic and Morphometry analysis of Cellular and Subcellular Structures of Rat Gastric Mucosa after Administration of E3810, a Novel Proton Pump Inhibitor

Journal of Toxicologic Pathology

Volumn 9, Issue 2, 1996, Pages 121-130

  Aoki, Toyohiko ^a   Fukuta, Taneo ^a   Hosokawa, Satoru ^a   Motooka, Satoru ^a   Nakanowatari, Junichi ^a   Sagami, Fumio ^a   Furuhashi, Masako ^b   Nakahara, Akira ^b   Fukutomi, Hisayuki ^b   Uchiyama, Yasuo ^c  

^a EISAI CO LTD   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

E3810; ECL cell; Gastrin; Morphometry; Proton pump inhibitor

Indexed keywords

EID: 2042437205     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.9.121     Document Type: Article

References (28)

1. Morii, M, Takata, H, Fujisaki, H, and Takeguchi, N: The potency of substituted benzimidazole such as E3810, omeprazole, RO 18-5364 to inhibit gastric H+, K+-ATPase is correlated with the rate of acid-activation of the inhibitor. Biochem Pharmacol 39 : 661-677, 1990.
2. Fujisaki, H, Shibata, H, Oketani, K, Murakami, M, Fujimoto, M, Wakabayashi, T, Yamatsu, I, and Takeguchi, N: Effects of the proton pump inhibitor, E3810, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Drug Invest 3: 328-332, 1991.
3. Ando, T, Sasaki, S, Mayahara, H, and Miyajima, H: Morphological study on the stomach of the rats treated with orally with lansoprazole (AG-1749) for 4 and 13 weeks (in Japanese). Jpn Pharmacol Ther 20 : 43254334, 1992.
4. Furuhashi, M, Nakahara, A, Fukutomi, H, Kominami, E, and Uchiyama, Y : Changes in subcellular structures of parietal cells in the rat gastric gland after omeprazole. Arch Histol Cytol 55: 191-201, 1992.
5. Karasawa, H, Tani, N, Hara, M, Mutoh, N, Kondoh, H, Kimura, N, Watanabe, J, and Miwa, T: Inhibition of acid secretion of proton pump inhibitor (omeprazole) and effects to fundic mucosa (in Japanese). In: Recent progress in research on the proton pump inhibitor, A Yachi Ed, Nihon-Igakukan, Tokyo, Japan, 1989.
6. Kawai, T, Iguchi, H, Sasaki, Y, Kawai, K, Seki, T, Harada, Y, and Saitoh, T: Effects of proton pump inhibitor to gastric mucosal morphology and acetic acid-induced ulcers: Especially related to the cell proliferation activities (in Japanese). In: Recent progress in research on the proton pump inhibitor, A Yachi Ed, Nihon-Igakukan, Tokyo, Japan, 1989.
7. Larrson, H, Carlsson, E, Mattsson, H, Lundell, L, Sundler F, Sundell, G, Wallmark, B, Watanabe, T, and Hakanson, R : Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation, Study with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 90: 391-399, 1986.
8. Ryberg, B, Tielemans, Y, Axelson, J, Carlsson, E, Hakanson, R, Matsson, H, Sundler, F, and Willems, G: Gastrin stimulates the self-replication rate of enterochrmaffinlike cells in the rat stomach, effect of omeprazole, ranitidine and gastrin-17 in intact and antrectomized rats. Gastroenterology 99: 935-942, 1990.
9. Hakanson, R, Bottcher, G, Sundler, F, and Vallfren, S: Activation and hyperplasia of gastrin and enterochromaffinlike cells in the stomach. Digestion 35(suppl 1): 23-41, 1986.
10. Watanabe, T, Hosokawa, S, Miyagawa, H, Ogura, K, Tomimatsu, M, Kato, S, Igarashi, T, and Yamatsu, K: Thirteen weeks oral subacute toxicity study of E3810 in rats by gavage and followed by a 5-week recovery period (in Japanese). G.I. Res 1: 514-526, 1993.
11. Noguchi, M, Nakanowatari, J, Tanabe, Y, Tagaya, O, Aoki, T, and Yamatsu, K: Thirteen weeks oral subacute toxichity study of E3810 in beagle dogs and a 5-week recovery period, (in Japanese). G.I. Res 1: 527-556, 1993.
12. Danks, A, Holmes, P, Sparrow, S, Virgo, DM, Aoki, T, Hosokawa, S, Motooka, S, and Yamatsu, K: 52-week oral (gavage) toxicity study with 26-week reversibility period in rats with E3810. G.I. Res 1: 557-573, 1993.
13. Danks, A, Holmes, P, Sparrow, S, Virgo, DM, Aoki, T, Hayakawa, S, Motooka, S, and Yamatsu, K: 52-week oral (capsule) toxicity study with 26-week reversibility period in dogs with E3810. G.I. Res 1: 574-600, 1993.
14. Fujisaki, H, Shibata, H, Oketani, K, Murakami, M, Fujimoto, M, Wakabayashi, T, Yamatsu, I, Yamaguchi, M, Sakai, H, and Takeguchi, N: Inhibitions of acid secretion by E3810 and omeprazole and their reversal by glutathione. Biochem Pharmacol 42: 321-328, 1991.
15. Morii, M, Takahashi, R, Minami, K. et al: Different biochemical modes of action of two irreversible H+, K+-ATPase inhibitors, omeprazole and E3810. J Biol Chem 268: 21553-21559, 1993.
16. Harleman, JH, Betton, GR, Dormer, C, and McCrossan, M: Gastric neuroendocrine cell hyperplasia after treatment with the long-acting, potent H2-receptor antagonist SK & F93479. Scand J Gastroenterol 22 : 595600, 1987.
17. Watanabe, M, and Uchiyama, Y: Twenty-four hour variations in subcellular structures of rat pancreatic islet B-, A-and D-cells, and of portal plasma glucose and insulin levels. Cell Tiss Res 253 : 337-345, 1988.
18. Weibel, ER: Practical stereological methods for mor-phometric cytology. J Cell Biol 30: 23-38, 1966.
19. Betton, GR, Dormer, CS, Wells, T, Pert, P, Price, CA, and Buckley, P: Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK & F93479 and oxmetidine and omeprazole. Toxicol Pathol 16 : 381-387, 1987.
20. Creutzfeldt, W, Stockmann, F, Conlon, JM, Folsch, UR, Bonatz, G, and Wulfrath, M: Effect of short-and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion 35(Suppl 1): 84-97, 1988.
21. Hirth, RS, Evans, LD, Buroker, RA, and Oleson, FB: Gastric enterochromaffin-like cell hyperplasia and neoplasia in the rat: An indirect effect of the histamine IE-receptor antagonist, BL-6341. Toxicol Pathol 16: 273-287, 1988.
22. Tielemans, Y, Håkanson, R, Sundler, F, and Willems, G : Proliferation of enterochromaffinlike cells in omeprazole-treated hypergastrinemic rats. Gastroenterology 96 : 723-727, 1989.
23. Wallmark, B, Skanberg, I, Mattsson, H, Andeisson, K, Sundler, F, Hakanson, R, and Carlsson, E: Effect of 20 weeks' ranitidine treatment on plasma gastrin levels and gastric enterochromaffin-like cell density in the rat Digestion 45: 181-188, 1990.
24. Helander, HF: Parietal cell structure during inhibition of acid secretion. Scand J Gastroenterol 19(suppl 101): 21-26, 1984.
25. Fiyklund, J, and Helander, HF: Function and structure of parietal cells after H+-K+ATPase blockage. Am J Physiol 254: G339-G407, 1988.
26. Karasawa, H, Tani, N, and Miwa, T: The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol Jpn 23: 1-8, 1988.
27. Pillary, CV, Somers, S, Booyens, J, Moshal, MG, and Bryer, JV: The effect of acid-stimulating and inhibiting drugs on the ultrastructure of gastric parietal cells in man. South Afr Med J 51: 915-919, 1977.
28. Ito, S. and Schofield, GC : Studies on the depletion and accumulation of microvilli and changes in the tubulovesicular compartment of mouse parietal cells in relation to gastric acid secretion. J Cell Biol 63 : 364382, 1974.